The renin angiotensin system in endometrial cancer The novel long non-coding RNA RP1X induces N-Myc protein stabilization, tumour cell proliferation and survival Global Demethylation Increases XPC Expression and Overcomes Platinum Therapy Resistance in Melanoma  Increased density of somatic mutations at core promoters is linked to neutral selection and transcriptional activity Systematic Identification of Ubiquitin Ligase Substrates UBR5 Regulates Primary Cilia Formation via Interactions with Multiple Centriollar Proteins Excessive activation of the Src-kinase HCK in the tumor stroma promotes progression of solid tumors How to improve a good drug - Tales of the unexpected Molecular Imaging: A Window into Cancer A genome-wide, synthetic lethal screen for innate platinum-resistance genes in lung adenocarcinoma. Tackling Pancreatic Cancer using a Novel Nanotechnology-siRNA Therapeutic  Transcriptional regulation of mammary gland lineage commitment by Inhibitor of Differentiation 4 (Id4) Rational therapies and Moving Targets Constraining healthcare expenditures and determining value for genomic medicine in oncology Working together to catalyse the discovery of pioneer targets for cancer drug discovery: creating a new, more efficient ecosystem Discovery of a small molecule TUBB3/βIII-tubulin modulator in lung cancer THIOIMIDAZOLINE BASED COMPOUNDS REVERSE GLUCOCORTICOID RESISTANCE IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA  BIOLUMINESCENCE IMAGING ENHANCES ANALYSIS OF DRUG RESPONSE IN A PATIENT-DERIVED XENOGRAFT MODEL OF PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA Discovery of CTx-0391034 a novel potent and selective inhibitor of PRMT5 TBA DNA methylation of estrogen regulated enhancers defines endocrine sensitivity in breast cancer Targeting Vascular Remodelling in Cancer Overcoming resistance to therapies targeting oncogenes Paediatric glioblastoma: unique targets in unique diseases Biomarker-driven cancer therapy